If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
91.00    0.00 (0.00%)
Bid:
90.00
Ask:
92.00
Spread: 2.00 (2.222%)
Market Cap: £60.38m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

R&D Day

13 Mar 2025 07:00

RNS Number : 4590A
Eco Animal Health Group PLC
13 March 2025
 

13 March 2025

 

 

 

ECO Animal Health Group plc

("ECO" or the "Company")

 

R&D Day

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that it is hosting an R&D Day today for institutional and private investors and analysts, with presentations starting at 2:00pm GMT at Andaz London, 40 Liverpool St, London EC2M 7QN.

The event will be led by David Hallas, CEO, and Chris Wilks, CFO, alongside senior leaders from across the Company and an industry expert. Attendees will have the opportunity to gain valuable insights on how the next generation of assets in ECO's R&D pipeline are driving long-term value creation and future proofing the business through innovations in preventative animal health.

For those who would like to join virtually, please register via the dedicated registration page: https://www.equitydevelopment.co.uk/news-and-events/eah-rd-investor-presentation-13march2025.

No new information will be provided on current trading at the R&D Day. For guidance on FY25 trading, the Company asks investors to review the outlook section of the interim results announced on 28 November 2024 as this remains relevant. The Company will provide a trading update for the year ending 31 March 2025 in April 2025.

 

Following the event, slides and a recording will be made available for viewing on the Investors section of the Company's website.

 

 

 

-Ends-

For further information please contact:

ECO Animal Health Group plc

David Hallas (CEO)

Christopher Wilks (CFO)

020 8447 8899

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Phil Davies

Sam Butcher

020 7496 3000

Investec (Joint Broker)

Gary Clarence

Lydia Zychowska

020 7597 5970

 

 

Equity Development

Hannah Crowe

Matt Evans

020 7065 2692

ICR Healthcare (Financial PR)

Mary-Jane Elliott

Jessica Hodgson

020 3709 5700

ecoanimalhealth@consilium-comms.com

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. 

Click here for more information: https://ecoanimalhealth.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGMFLZLGKZM
Date   Source Headline
26th Jul 20107:00 amBUSRegulatory Approval
30th Jul 20087:00 amRNSPreliminary Results
17th Dec 20077:00 amRNSInterim Results
23rd Jul 20077:00 amRNSFinal Results
23rd Jul 20077:00 amRNSIssue of Equity
27th Nov 200611:56 amRNSResult of EGM
3rd Nov 20067:30 amRNSAcquistion and Placing
13th Oct 200611:30 amRNSStatement re. Disposal
13th Oct 200611:30 amRNSPossible Acquisition
26th Jul 20067:01 amRNSFinal Results
7th Apr 200611:31 amRNSSAR 3 - Lawrence Plc
7th Mar 200611:47 amRNSSAR 3 - Lawrence Plc
13th Feb 20067:01 amRNSTrading Statement
26th Jan 200611:47 amRNSSAR 3 - Lawrence Plc
12th Dec 20057:01 amRNSInterim Results
23rd Nov 200512:58 pmRNSSAR 3 - Lawrence Plc
27th Oct 200510:56 amRNSSAR 3 - Lawrence Plc
5th Sep 200510:52 amRNSSAR 3 - Lawrence Plc
29th Jul 20057:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.